The more widespread pathology in the broader range of α-synucleinopathies, including dementia with Lewy bodies and multiple system atrophy, compared with parkinsonism caused by mutations in the genes encoding parkin and PINK1, might reflect additional cellular targets of excess actin stabilization. The gene discussed is PINK1; the disease is synucleinopathy.